Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
Clinical trial NCT01478178 · COMPLETED
Trial details
- NCT number
- NCT01478178
- Sponsor
- Kintara Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.